VIRGINIA COMMONWEALTH UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1838-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.vcu.edu
Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Pulmonary Hypertension
Phase 1
Terminated
- Conditions
- Pulmonary Hypertension
- Interventions
- First Posted Date
- 2011-11-24
- Last Posted Date
- 2017-11-13
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 2
- Registration Number
- NCT01479010
- Locations
- 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States
Intra-abdominal at Cesarean Section: A Randomized Controlled Trial
Not Applicable
Completed
- Conditions
- NauseaVomiting
- Interventions
- Procedure: Normal Saline Irrigation
- First Posted Date
- 2011-11-24
- Last Posted Date
- 2011-11-24
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 263
- Registration Number
- NCT01479712
- Locations
- 🇺🇸
Virginia Commonwealth University Hospital System, Richmond, Virginia, United States
Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women
Phase 4
Completed
- Conditions
- Insulin SensitivityPerimenopausal DisorderCardiovascular Risk
- Interventions
- Drug: Ortho Cyclen®
- First Posted Date
- 2011-11-21
- Last Posted Date
- 2018-08-08
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 47
- Registration Number
- NCT01475513
- Locations
- 🇺🇸
Virginia Commonwealth University Medical Center, Richmond, Virginia, United States
Insulin Resistance Before and During Pregnancy in Women With Polycystic Ovary Syndrome
Terminated
- Conditions
- ObesityPregnancyPolycystic Ovary SyndromeInsulin ResistanceInsulin Sensitivity
- First Posted Date
- 2011-11-21
- Last Posted Date
- 2015-12-14
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 2
- Registration Number
- NCT01475565
- Locations
- 🇺🇸
Virginia Commonwealth University Medical Center, Richmond, Virginia, United States
Reduce Cardiovascular Risk in Women Through Tai Chi Intervention
Not Applicable
Completed
- Conditions
- Cardiometabolic RiskCardiovascular Disease
- Interventions
- Other: Tai Chi class
- First Posted Date
- 2011-11-08
- Last Posted Date
- 2013-05-21
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 96
- Registration Number
- NCT01467544
- Locations
- 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States
Study to Explore the Relationships Among Immunity and Stress and the Symptoms of Fatigue, Pain, and Mood Following Guided Imagery in Women With Fibromyalgia
Not Applicable
Completed
- Conditions
- Fibromyalgia
- Interventions
- Other: Guided Imagery
- First Posted Date
- 2011-10-18
- Last Posted Date
- 2011-10-18
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 72
- Registration Number
- NCT01453647
- Locations
- 🇺🇸
Virginia Common Wealth University Health System, Richmond, Virginia, United States
Pemetrexed Disodium and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors
Phase 1
Completed
- Conditions
- Unspecified Adult Solid Tumor
- Interventions
- Other: laboratory biomarker analysisProcedure: biopsy
- First Posted Date
- 2011-10-12
- Last Posted Date
- 2016-02-23
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 37
- Registration Number
- NCT01450384
- Locations
- 🇺🇸
Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States
Effectiveness of Guided Imagery Intervention on Factors Associated With Maternal Stress and Preterm Birth
Not Applicable
Completed
- Conditions
- Preterm BirthMaternal Stress
- Interventions
- Other: Guided Imagery
- First Posted Date
- 2011-09-20
- Last Posted Date
- 2014-05-16
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 73
- Registration Number
- NCT01436786
- Locations
- 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States
Ascorbic Acid (Vitamin C) Infusion in Human Sepsis
Phase 1
Completed
- Conditions
- SepsisHypotensionAcute Lung InjurySeptic Shock
- Interventions
- Drug: Placebo
- First Posted Date
- 2011-09-14
- Last Posted Date
- 2018-02-01
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 24
- Registration Number
- NCT01434121
- Locations
- 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States
Randomized RT +/- Lapatinib for Advanced Solid Tumor Cancer Patients Receiving Radiation Therapy for Metastatic Disease
Early Phase 1
Terminated
- Conditions
- Epithelial Cancer
- Interventions
- Radiation: Radiation therapy
- First Posted Date
- 2011-09-01
- Last Posted Date
- 2015-07-08
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 6
- Registration Number
- NCT01427322
- Locations
- 🇺🇸
Hunter Holmes McGuire VA Medical Center, Richmond, Virginia, United States
🇺🇸Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia, United States
© Copyright 2025. All Rights Reserved by MedPath